ANGIOTECH PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - March 16, 2010

Attached files

file filename
10-K - FORM 10-K - ANGIOTECH PHARMACEUTICALS INCd10k.htm
EX-21 - LIST OF WORLDWIDE SUBSIDIARIES - ANGIOTECH PHARMACEUTICALS INCdex21.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex311.htm
EX-14.2 - GUIDE OF BUSINESS CONDUCT - ANGIOTECH PHARMACEUTICALS INCdex142.htm
EX-14.1 - CODE OF ETHICS FOR CEO, CFO AND SVP FINANCE - ANGIOTECH PHARMACEUTICALS INCdex141.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex312.htm
EX-32.1 - CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 - ANGIOTECH PHARMACEUTICALS INCdex321.htm
EX-10.29 - EXECUTIVE EMPLOYMENT AGREEMENT - ANGIOTECH PHARMACEUTICALS INCdex1029.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-160759) and in the Registration Statement on Form S-8 (No. 333-159222) of our report dated March 16, 2010 relating to the consolidated financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/PricewaterhouseCoopers LLP

Vancouver, British Columbia

March 16, 2010

ANGIOTECH PHARMACEUTICALS INC Reports

Also read